Showing results (171-180 of 976) with videos related to
Sort By:
Pageof 98
NPJ Breast Cancer|March 4, 2025
Real-World outcomes with sacituzumab govitecan among breast cancer patients with central nervous system metastasesThomas Grinda, Stefania Morganti, Liangge Hsu, et al.NPJ Breast Cancer|March 7, 2025
Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trialIoannis Zerdes, Alexios Matikas, Artur Mezheyeuski, et al.NPJ Breast Cancer|August 20, 2024
Efficacy of FERscore in predicting sensitivity to ferroptosis inducers in breast cancerKaimin Hu, Jili Qiu, Yue Hu, et al.NPJ Breast Cancer|August 22, 2024
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancerEmi Noguchi, Takashi Yamanaka, Hirofumi Mukai, et al.NPJ Breast Cancer|August 21, 2024
Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502Daniel G Stover, Roberto Salgado, Oleksander Savenkov, et al.NPJ Breast Cancer|November 26, 2024
Immune environment of high-TIL breast cancer: triple negative and hormone receptor positive HER2 negativeSu-Jin Shin, Inho Park, Heounjeong Go, et al.NPJ Breast Cancer|November 14, 2024
Performance of an AI-powered visualization software platform for precision surgery in breast cancer patientsMichelle Weitz, J R Pfeiffer, Snehal Patel, et al.NPJ Breast Cancer|October 29, 2024
Invasive disease-free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumabS M Chew, E Ferraro, Y Chen, et al.NPJ Breast Cancer|July 19, 2024
Gene expression signature for predicting homologous recombination deficiency in triple-negative breast cancerJia-Wern Pan, Zi-Ching Tan, Pei-Sze Ng, et al.NPJ Breast Cancer|July 17, 2024
Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY studySimone Scagnoli, Simona Pisegna, Angela Toss, et al.Pageof 98